nodes	percent_of_prediction	percent_of_DWPC	metapath
Crizotinib—MET—pancreatitis	0.613	1	CbGaD
Crizotinib—Balance disorder—Hyoscyamine—pancreatitis	0.00299	0.093	CcSEcCtD
Crizotinib—Visual acuity reduced—Hyoscyamine—pancreatitis	0.00275	0.0855	CcSEcCtD
Crizotinib—Electrocardiogram QT prolonged—Hyoscyamine—pancreatitis	0.00255	0.0792	CcSEcCtD
Crizotinib—Haemoglobin decreased—Hyoscyamine—pancreatitis	0.00238	0.0739	CcSEcCtD
Crizotinib—PRKD3—islet of Langerhans—pancreatitis	0.0022	0.0199	CbGeAlD
Crizotinib—PTK2—exocrine gland—pancreatitis	0.00201	0.0182	CbGeAlD
Crizotinib—MET—islet of Langerhans—pancreatitis	0.0019	0.0172	CbGeAlD
Crizotinib—ACVR1B—islet of Langerhans—pancreatitis	0.00176	0.0159	CbGeAlD
Crizotinib—Respiratory failure—Hyoscyamine—pancreatitis	0.00167	0.0518	CcSEcCtD
Crizotinib—PRKD3—pancreas—pancreatitis	0.00154	0.014	CbGeAlD
Crizotinib—Photophobia—Hyoscyamine—pancreatitis	0.00154	0.0477	CcSEcCtD
Crizotinib—NEK9—digestive system—pancreatitis	0.0015	0.0136	CbGeAlD
Crizotinib—NEK9—blood—pancreatitis	0.00143	0.013	CbGeAlD
Crizotinib—MAPK7—pancreas—pancreatitis	0.00143	0.0129	CbGeAlD
Crizotinib—TESK1—islet of Langerhans—pancreatitis	0.0014	0.0127	CbGeAlD
Crizotinib—PRKD1—digestive system—pancreatitis	0.00137	0.0124	CbGeAlD
Crizotinib—MET—pancreas—pancreatitis	0.00133	0.0121	CbGeAlD
Crizotinib—NUAK2—islet of Langerhans—pancreatitis	0.00133	0.0121	CbGeAlD
Crizotinib—ACVR1—islet of Langerhans—pancreatitis	0.00132	0.012	CbGeAlD
Crizotinib—Vision blurred—Propantheline—pancreatitis	0.00132	0.0409	CcSEcCtD
Crizotinib—STK35—islet of Langerhans—pancreatitis	0.00129	0.0117	CbGeAlD
Crizotinib—LIMK1—blood—pancreatitis	0.00129	0.0117	CbGeAlD
Crizotinib—PRKD3—blood—pancreatitis	0.00126	0.0114	CbGeAlD
Crizotinib—ACVR1B—pancreas—pancreatitis	0.00123	0.0112	CbGeAlD
Crizotinib—BLK—blood—pancreatitis	0.00121	0.011	CbGeAlD
Crizotinib—RIPK2—islet of Langerhans—pancreatitis	0.00119	0.0108	CbGeAlD
Crizotinib—MAPK7—blood—pancreatitis	0.00116	0.0105	CbGeAlD
Crizotinib—TXK—blood—pancreatitis	0.00116	0.0105	CbGeAlD
Crizotinib—FES—blood—pancreatitis	0.00115	0.0104	CbGeAlD
Crizotinib—MET—digestive system—pancreatitis	0.00114	0.0103	CbGeAlD
Crizotinib—PTK2—islet of Langerhans—pancreatitis	0.00111	0.01	CbGeAlD
Crizotinib—TBK1—islet of Langerhans—pancreatitis	0.00111	0.01	CbGeAlD
Crizotinib—TYK2—islet of Langerhans—pancreatitis	0.0011	0.00998	CbGeAlD
Crizotinib—MET—blood—pancreatitis	0.00109	0.00985	CbGeAlD
Crizotinib—IRAK1—islet of Langerhans—pancreatitis	0.00109	0.00985	CbGeAlD
Crizotinib—Hypokalaemia—Hyoscyamine—pancreatitis	0.00108	0.0336	CcSEcCtD
Crizotinib—IGF1R—pancreas—pancreatitis	0.00105	0.00951	CbGeAlD
Crizotinib—TAOK2—blood—pancreatitis	0.00104	0.00945	CbGeAlD
Crizotinib—SLK—islet of Langerhans—pancreatitis	0.00102	0.00921	CbGeAlD
Crizotinib—EPHB4—islet of Langerhans—pancreatitis	0.00101	0.00914	CbGeAlD
Crizotinib—JAK3—digestive system—pancreatitis	0.00101	0.00911	CbGeAlD
Crizotinib—DCLK1—digestive system—pancreatitis	0.000999	0.00906	CbGeAlD
Crizotinib—EPHA2—islet of Langerhans—pancreatitis	0.000989	0.00897	CbGeAlD
Crizotinib—STK4—digestive system—pancreatitis	0.000987	0.00895	CbGeAlD
Crizotinib—Constipation—Propantheline—pancreatitis	0.000975	0.0303	CcSEcCtD
Crizotinib—MAP4K5—islet of Langerhans—pancreatitis	0.000965	0.00875	CbGeAlD
Crizotinib—JAK3—blood—pancreatitis	0.000958	0.00868	CbGeAlD
Crizotinib—PLK4—blood—pancreatitis	0.000946	0.00858	CbGeAlD
Crizotinib—STK4—blood—pancreatitis	0.00094	0.00852	CbGeAlD
Crizotinib—NUAK2—pancreas—pancreatitis	0.000935	0.00848	CbGeAlD
Crizotinib—ALK—digestive system—pancreatitis	0.000933	0.00846	CbGeAlD
Crizotinib—EPHA5—digestive system—pancreatitis	0.000933	0.00846	CbGeAlD
Crizotinib—ACVR1—pancreas—pancreatitis	0.000928	0.00842	CbGeAlD
Crizotinib—EPHB6—islet of Langerhans—pancreatitis	0.000922	0.00836	CbGeAlD
Crizotinib—STK35—pancreas—pancreatitis	0.00091	0.00825	CbGeAlD
Crizotinib—IGF1R—digestive system—pancreatitis	0.000896	0.00812	CbGeAlD
Crizotinib—YES1—islet of Langerhans—pancreatitis	0.000891	0.00808	CbGeAlD
Crizotinib—ALK—blood—pancreatitis	0.000888	0.00806	CbGeAlD
Crizotinib—FER—blood—pancreatitis	0.000888	0.00806	CbGeAlD
Crizotinib—LYN—blood—pancreatitis	0.000884	0.00801	CbGeAlD
Crizotinib—TAOK3—islet of Langerhans—pancreatitis	0.00088	0.00798	CbGeAlD
Crizotinib—TNK1—blood—pancreatitis	0.000879	0.00797	CbGeAlD
Crizotinib—MAP4K1—blood—pancreatitis	0.00087	0.00789	CbGeAlD
Crizotinib—SRC—islet of Langerhans—pancreatitis	0.000857	0.00777	CbGeAlD
Crizotinib—IGF1R—blood—pancreatitis	0.000854	0.00774	CbGeAlD
Crizotinib—AURKA—digestive system—pancreatitis	0.000849	0.0077	CbGeAlD
Crizotinib—MAP4K2—blood—pancreatitis	0.000842	0.00763	CbGeAlD
Crizotinib—Bradycardia—Hyoscyamine—pancreatitis	0.000836	0.026	CcSEcCtD
Crizotinib—STK3—blood—pancreatitis	0.00083	0.00753	CbGeAlD
Crizotinib—Asthenia—Propantheline—pancreatitis	0.000818	0.0254	CcSEcCtD
Crizotinib—AURKA—blood—pancreatitis	0.000809	0.00734	CbGeAlD
Crizotinib—TESK1—blood—pancreatitis	0.000803	0.00728	CbGeAlD
Crizotinib—MERTK—blood—pancreatitis	0.000781	0.00708	CbGeAlD
Crizotinib—PTK2—pancreas—pancreatitis	0.000779	0.00706	CbGeAlD
Crizotinib—TBK1—pancreas—pancreatitis	0.000779	0.00706	CbGeAlD
Crizotinib—TYK2—pancreas—pancreatitis	0.000773	0.00701	CbGeAlD
Crizotinib—LIMK2—blood—pancreatitis	0.000764	0.00692	CbGeAlD
Crizotinib—IRAK1—pancreas—pancreatitis	0.000763	0.00692	CbGeAlD
Crizotinib—NUAK2—blood—pancreatitis	0.000761	0.0069	CbGeAlD
Crizotinib—MAP3K12—blood—pancreatitis	0.000755	0.00685	CbGeAlD
Crizotinib—ACVR1—blood—pancreatitis	0.000755	0.00685	CbGeAlD
Crizotinib—FLT3—blood—pancreatitis	0.000755	0.00685	CbGeAlD
Crizotinib—Dizziness—Propantheline—pancreatitis	0.000754	0.0234	CcSEcCtD
Crizotinib—RPS6KB1—pancreas—pancreatitis	0.000749	0.00679	CbGeAlD
Crizotinib—Arrhythmia—Hyoscyamine—pancreatitis	0.000734	0.0228	CcSEcCtD
Crizotinib—Vomiting—Propantheline—pancreatitis	0.000725	0.0225	CcSEcCtD
Crizotinib—PTK2B—digestive system—pancreatitis	0.000722	0.00655	CbGeAlD
Crizotinib—ABL2—blood—pancreatitis	0.000721	0.00654	CbGeAlD
Crizotinib—Rash—Propantheline—pancreatitis	0.000719	0.0223	CcSEcCtD
Crizotinib—Dermatitis—Propantheline—pancreatitis	0.000718	0.0223	CcSEcCtD
Crizotinib—RIPK2—digestive system—pancreatitis	0.000716	0.00649	CbGeAlD
Crizotinib—SLK—pancreas—pancreatitis	0.000714	0.00647	CbGeAlD
Crizotinib—BMP2K—blood—pancreatitis	0.000712	0.00646	CbGeAlD
Crizotinib—EPHB4—pancreas—pancreatitis	0.000709	0.00643	CbGeAlD
Crizotinib—Dysgeusia—Hyoscyamine—pancreatitis	0.0007	0.0218	CcSEcCtD
Crizotinib—EPHA2—pancreas—pancreatitis	0.000695	0.0063	CbGeAlD
Crizotinib—PTK2B—blood—pancreatitis	0.000688	0.00624	CbGeAlD
Crizotinib—RIPK2—blood—pancreatitis	0.000682	0.00619	CbGeAlD
Crizotinib—MAP4K5—pancreas—pancreatitis	0.000678	0.00615	CbGeAlD
Crizotinib—TEK—pancreas—pancreatitis	0.000678	0.00615	CbGeAlD
Crizotinib—Nausea—Propantheline—pancreatitis	0.000677	0.021	CcSEcCtD
Crizotinib—Vision blurred—Hyoscyamine—pancreatitis	0.000674	0.0209	CcSEcCtD
Crizotinib—TBK1—digestive system—pancreatitis	0.000665	0.00603	CbGeAlD
Crizotinib—PTK2—digestive system—pancreatitis	0.000665	0.00603	CbGeAlD
Crizotinib—TYK2—digestive system—pancreatitis	0.000661	0.00599	CbGeAlD
Crizotinib—EPHA4—blood—pancreatitis	0.00066	0.00598	CbGeAlD
Crizotinib—MAP3K2—blood—pancreatitis	0.000647	0.00587	CbGeAlD
Crizotinib—Syncope—Hyoscyamine—pancreatitis	0.000641	0.0199	CcSEcCtD
Crizotinib—RPS6KB1—digestive system—pancreatitis	0.00064	0.0058	CbGeAlD
Crizotinib—FGR—digestive system—pancreatitis	0.000636	0.00577	CbGeAlD
Crizotinib—PTK2—blood—pancreatitis	0.000634	0.00574	CbGeAlD
Crizotinib—TBK1—blood—pancreatitis	0.000634	0.00574	CbGeAlD
Crizotinib—TYK2—blood—pancreatitis	0.000629	0.00571	CbGeAlD
Crizotinib—Loss of consciousness—Hyoscyamine—pancreatitis	0.000629	0.0195	CcSEcCtD
Crizotinib—YES1—pancreas—pancreatitis	0.000626	0.00568	CbGeAlD
Crizotinib—IRAK1—blood—pancreatitis	0.000621	0.00563	CbGeAlD
Crizotinib—TAOK3—pancreas—pancreatitis	0.000618	0.00561	CbGeAlD
Crizotinib—RPS6KB1—blood—pancreatitis	0.000609	0.00553	CbGeAlD
Crizotinib—ABL1—islet of Langerhans—pancreatitis	0.000608	0.00552	CbGeAlD
Crizotinib—FGR—blood—pancreatitis	0.000606	0.00549	CbGeAlD
Crizotinib—LCK—blood—pancreatitis	0.000606	0.00549	CbGeAlD
Crizotinib—EPHB4—digestive system—pancreatitis	0.000605	0.00549	CbGeAlD
Crizotinib—SRC—pancreas—pancreatitis	0.000603	0.00546	CbGeAlD
Crizotinib—JAK2—digestive system—pancreatitis	0.000601	0.00545	CbGeAlD
Crizotinib—EPHA2—digestive system—pancreatitis	0.000594	0.00538	CbGeAlD
Crizotinib—Oedema—Hyoscyamine—pancreatitis	0.000584	0.0181	CcSEcCtD
Crizotinib—SLK—blood—pancreatitis	0.000581	0.00527	CbGeAlD
Crizotinib—EPHB4—blood—pancreatitis	0.000577	0.00523	CbGeAlD
Crizotinib—Shock—Hyoscyamine—pancreatitis	0.000574	0.0178	CcSEcCtD
Crizotinib—JAK2—blood—pancreatitis	0.000572	0.00519	CbGeAlD
Crizotinib—EPHA2—blood—pancreatitis	0.000566	0.00513	CbGeAlD
Crizotinib—MAP4K5—blood—pancreatitis	0.000552	0.005	CbGeAlD
Crizotinib—MAP3K3—blood—pancreatitis	0.000552	0.005	CbGeAlD
Crizotinib—TEK—blood—pancreatitis	0.000552	0.005	CbGeAlD
Crizotinib—YES1—digestive system—pancreatitis	0.000535	0.00485	CbGeAlD
Crizotinib—STK10—digestive system—pancreatitis	0.00053	0.00481	CbGeAlD
Crizotinib—TAOK3—digestive system—pancreatitis	0.000528	0.00479	CbGeAlD
Crizotinib—EPHB6—blood—pancreatitis	0.000527	0.00478	CbGeAlD
Crizotinib—Dyspnoea—Hyoscyamine—pancreatitis	0.00052	0.0162	CcSEcCtD
Crizotinib—SRC—digestive system—pancreatitis	0.000515	0.00467	CbGeAlD
Crizotinib—Dyspepsia—Hyoscyamine—pancreatitis	0.000514	0.016	CcSEcCtD
Crizotinib—YES1—blood—pancreatitis	0.00051	0.00462	CbGeAlD
Crizotinib—STK10—blood—pancreatitis	0.000505	0.00458	CbGeAlD
Crizotinib—Fatigue—Hyoscyamine—pancreatitis	0.000503	0.0156	CcSEcCtD
Crizotinib—TAOK3—blood—pancreatitis	0.000503	0.00456	CbGeAlD
Crizotinib—Constipation—Hyoscyamine—pancreatitis	0.000499	0.0155	CcSEcCtD
Crizotinib—SRC—blood—pancreatitis	0.00049	0.00445	CbGeAlD
Crizotinib—CSF1R—digestive system—pancreatitis	0.000462	0.00419	CbGeAlD
Crizotinib—Body temperature increased—Hyoscyamine—pancreatitis	0.000461	0.0143	CcSEcCtD
Crizotinib—CSF1R—blood—pancreatitis	0.00044	0.00399	CbGeAlD
Crizotinib—ABL1—pancreas—pancreatitis	0.000428	0.00388	CbGeAlD
Crizotinib—Asthenia—Hyoscyamine—pancreatitis	0.000419	0.013	CcSEcCtD
Crizotinib—Diarrhoea—Hyoscyamine—pancreatitis	0.000399	0.0124	CcSEcCtD
Crizotinib—Dizziness—Hyoscyamine—pancreatitis	0.000386	0.012	CcSEcCtD
Crizotinib—Vomiting—Hyoscyamine—pancreatitis	0.000371	0.0115	CcSEcCtD
Crizotinib—Rash—Hyoscyamine—pancreatitis	0.000368	0.0114	CcSEcCtD
Crizotinib—Dermatitis—Hyoscyamine—pancreatitis	0.000368	0.0114	CcSEcCtD
Crizotinib—ABL1—digestive system—pancreatitis	0.000365	0.00331	CbGeAlD
Crizotinib—CYP3A5—islet of Langerhans—pancreatitis	0.000356	0.00323	CbGeAlD
Crizotinib—ABL1—blood—pancreatitis	0.000348	0.00315	CbGeAlD
Crizotinib—Nausea—Hyoscyamine—pancreatitis	0.000347	0.0108	CcSEcCtD
Crizotinib—CYP3A5—pancreas—pancreatitis	0.00025	0.00227	CbGeAlD
Crizotinib—CYP3A5—digestive system—pancreatitis	0.000214	0.00194	CbGeAlD
Crizotinib—CYP3A5—blood—pancreatitis	0.000204	0.00185	CbGeAlD
Crizotinib—ABCB1—islet of Langerhans—pancreatitis	0.000189	0.00172	CbGeAlD
Crizotinib—CYP3A4—digestive system—pancreatitis	0.00016	0.00145	CbGeAlD
Crizotinib—CYP3A4—blood—pancreatitis	0.000153	0.00139	CbGeAlD
Crizotinib—ABCB1—pancreas—pancreatitis	0.000133	0.00121	CbGeAlD
Crizotinib—ABCB1—digestive system—pancreatitis	0.000114	0.00103	CbGeAlD
Crizotinib—ABCB1—blood—pancreatitis	0.000108	0.000981	CbGeAlD
Crizotinib—LYN—Innate Immune System—HRAS—pancreatitis	3.09e-06	1.26e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—GCG—pancreatitis	3.09e-06	1.26e-05	CbGpPWpGaD
Crizotinib—ABL1—Innate Immune System—HRAS—pancreatitis	3.08e-06	1.26e-05	CbGpPWpGaD
Crizotinib—PTK2B—Immune System—HRAS—pancreatitis	3.07e-06	1.26e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—ALDH2—pancreatitis	3.07e-06	1.26e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—MDM2—pancreatitis	3.07e-06	1.26e-05	CbGpPWpGaD
Crizotinib—SRC—Innate Immune System—NRAS—pancreatitis	3.06e-06	1.25e-05	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—HRAS—pancreatitis	3.06e-06	1.25e-05	CbGpPWpGaD
Crizotinib—TYK2—Immune System—NRAS—pancreatitis	3.04e-06	1.24e-05	CbGpPWpGaD
Crizotinib—CDK7—Disease—HRAS—pancreatitis	3.02e-06	1.23e-05	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—TNF—pancreatitis	3.01e-06	1.23e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—CASP3—pancreatitis	3.01e-06	1.23e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—HTR2A—pancreatitis	3e-06	1.23e-05	CbGpPWpGaD
Crizotinib—BLK—Immune System—HRAS—pancreatitis	3e-06	1.23e-05	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—IL6—pancreatitis	3e-06	1.23e-05	CbGpPWpGaD
Crizotinib—FGR—Immune System—HRAS—pancreatitis	2.99e-06	1.22e-05	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—KRAS—pancreatitis	2.99e-06	1.22e-05	CbGpPWpGaD
Crizotinib—RIPK2—Immune System—IL6—pancreatitis	2.99e-06	1.22e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—CCL5—pancreatitis	2.98e-06	1.22e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—LEP—pancreatitis	2.98e-06	1.22e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—INS—pancreatitis	2.98e-06	1.22e-05	CbGpPWpGaD
Crizotinib—LCK—Innate Immune System—KRAS—pancreatitis	2.98e-06	1.22e-05	CbGpPWpGaD
Crizotinib—LYN—Adaptive Immune System—HRAS—pancreatitis	2.97e-06	1.21e-05	CbGpPWpGaD
Crizotinib—LYN—Innate Immune System—IL6—pancreatitis	2.96e-06	1.21e-05	CbGpPWpGaD
Crizotinib—ABL1—Innate Immune System—IL6—pancreatitis	2.94e-06	1.2e-05	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—NRAS—pancreatitis	2.94e-06	1.2e-05	CbGpPWpGaD
Crizotinib—PTK2B—Immune System—IL6—pancreatitis	2.94e-06	1.2e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—IL1B—pancreatitis	2.94e-06	1.2e-05	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—IL6—pancreatitis	2.93e-06	1.2e-05	CbGpPWpGaD
Crizotinib—SRC—Hemostasis—KRAS—pancreatitis	2.93e-06	1.2e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—IL1B—pancreatitis	2.93e-06	1.2e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—LPL—pancreatitis	2.92e-06	1.19e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—PDGFA—pancreatitis	2.9e-06	1.19e-05	CbGpPWpGaD
Crizotinib—JAK2—Innate Immune System—HRAS—pancreatitis	2.89e-06	1.18e-05	CbGpPWpGaD
Crizotinib—CDK7—Disease—IL6—pancreatitis	2.89e-06	1.18e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—MDM2—pancreatitis	2.88e-06	1.18e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—XDH—pancreatitis	2.88e-06	1.18e-05	CbGpPWpGaD
Crizotinib—PTK2—Immune System—KRAS—pancreatitis	2.88e-06	1.18e-05	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—TGFB1—pancreatitis	2.87e-06	1.18e-05	CbGpPWpGaD
Crizotinib—BLK—Immune System—IL6—pancreatitis	2.87e-06	1.17e-05	CbGpPWpGaD
Crizotinib—FGR—Immune System—IL6—pancreatitis	2.86e-06	1.17e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling by GPCR—KRAS—pancreatitis	2.86e-06	1.17e-05	CbGpPWpGaD
Crizotinib—LCK—Adaptive Immune System—KRAS—pancreatitis	2.86e-06	1.17e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—MDM2—pancreatitis	2.84e-06	1.16e-05	CbGpPWpGaD
Crizotinib—YES1—Immune System—KRAS—pancreatitis	2.84e-06	1.16e-05	CbGpPWpGaD
Crizotinib—JAK2—Disease—MDM2—pancreatitis	2.83e-06	1.16e-05	CbGpPWpGaD
Crizotinib—LCK—Hemostasis—HRAS—pancreatitis	2.81e-06	1.15e-05	CbGpPWpGaD
Crizotinib—TYK2—Disease—NRAS—pancreatitis	2.8e-06	1.15e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—LEP—pancreatitis	2.79e-06	1.14e-05	CbGpPWpGaD
Crizotinib—JAK2—Innate Immune System—IL6—pancreatitis	2.77e-06	1.13e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—SPP1—pancreatitis	2.76e-06	1.13e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—NRAS—pancreatitis	2.76e-06	1.13e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—IL1B—pancreatitis	2.75e-06	1.13e-05	CbGpPWpGaD
Crizotinib—JAK2—Disease—PTGS2—pancreatitis	2.73e-06	1.12e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—NRAS—pancreatitis	2.72e-06	1.11e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—MDM2—pancreatitis	2.7e-06	1.1e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—CXCL8—pancreatitis	2.7e-06	1.1e-05	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—KRAS—pancreatitis	2.69e-06	1.1e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—MDM2—pancreatitis	2.69e-06	1.1e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—ADH1B—pancreatitis	2.69e-06	1.1e-05	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—KRAS—pancreatitis	2.66e-06	1.09e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—CXCL8—pancreatitis	2.66e-06	1.09e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—CCL5—pancreatitis	2.64e-06	1.08e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—INS—pancreatitis	2.64e-06	1.08e-05	CbGpPWpGaD
Crizotinib—SRC—Innate Immune System—KRAS—pancreatitis	2.64e-06	1.08e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—HTR2A—pancreatitis	2.63e-06	1.08e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—MDM2—pancreatitis	2.62e-06	1.07e-05	CbGpPWpGaD
Crizotinib—TYK2—Immune System—KRAS—pancreatitis	2.61e-06	1.07e-05	CbGpPWpGaD
Crizotinib—TYK2—Disease—TGFB1—pancreatitis	2.61e-06	1.07e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—NRAS—pancreatitis	2.6e-06	1.06e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—LPL—pancreatitis	2.58e-06	1.06e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—CASP3—pancreatitis	2.58e-06	1.06e-05	CbGpPWpGaD
Crizotinib—ABCB1—Transmembrane transport of small molecules—ALB—pancreatitis	2.56e-06	1.05e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—TGFB1—pancreatitis	2.56e-06	1.05e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—INS—pancreatitis	2.55e-06	1.04e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—CASP3—pancreatitis	2.54e-06	1.04e-05	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—HRAS—pancreatitis	2.54e-06	1.04e-05	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—KRAS—pancreatitis	2.53e-06	1.04e-05	CbGpPWpGaD
Crizotinib—LCK—Innate Immune System—HRAS—pancreatitis	2.53e-06	1.04e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—TGFB1—pancreatitis	2.52e-06	1.03e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—CXCL8—pancreatitis	2.52e-06	1.03e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—NRAS—pancreatitis	2.52e-06	1.03e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—NRAS—pancreatitis	2.52e-06	1.03e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—CCL2—pancreatitis	2.51e-06	1.03e-05	CbGpPWpGaD
Crizotinib—SRC—Hemostasis—HRAS—pancreatitis	2.49e-06	1.02e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—MDM2—pancreatitis	2.48e-06	1.02e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—NRAS—pancreatitis	2.46e-06	1.01e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—NRAS—pancreatitis	2.45e-06	1e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—CXCL8—pancreatitis	2.45e-06	1e-05	CbGpPWpGaD
Crizotinib—PTK2—Immune System—HRAS—pancreatitis	2.45e-06	1e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—SPP1—pancreatitis	2.45e-06	1e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—LEP—pancreatitis	2.45e-06	1e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling by GPCR—HRAS—pancreatitis	2.43e-06	9.95e-06	CbGpPWpGaD
Crizotinib—LCK—Adaptive Immune System—HRAS—pancreatitis	2.43e-06	9.95e-06	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—IL6—pancreatitis	2.43e-06	9.94e-06	CbGpPWpGaD
Crizotinib—LCK—Innate Immune System—IL6—pancreatitis	2.42e-06	9.92e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—LPL—pancreatitis	2.42e-06	9.91e-06	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—TGFB1—pancreatitis	2.42e-06	9.88e-06	CbGpPWpGaD
Crizotinib—TYK2—Disease—KRAS—pancreatitis	2.41e-06	9.88e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—CASP3—pancreatitis	2.41e-06	9.87e-06	CbGpPWpGaD
Crizotinib—YES1—Immune System—HRAS—pancreatitis	2.41e-06	9.87e-06	CbGpPWpGaD
Crizotinib—LCK—Immune System—IL1B—pancreatitis	2.41e-06	9.86e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—PTGS2—pancreatitis	2.39e-06	9.79e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—INS—pancreatitis	2.39e-06	9.76e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—MDM2—pancreatitis	2.38e-06	9.74e-06	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—KRAS—pancreatitis	2.37e-06	9.71e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—CCL2—pancreatitis	2.35e-06	9.6e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—CASP3—pancreatitis	2.34e-06	9.59e-06	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—TGFB1—pancreatitis	2.34e-06	9.58e-06	CbGpPWpGaD
Crizotinib—PTK2—Immune System—IL6—pancreatitis	2.34e-06	9.58e-06	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—KRAS—pancreatitis	2.34e-06	9.57e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—GCG—pancreatitis	2.33e-06	9.53e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—HTR2A—pancreatitis	2.33e-06	9.53e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling by GPCR—IL6—pancreatitis	2.33e-06	9.52e-06	CbGpPWpGaD
Crizotinib—YES1—Immune System—IL6—pancreatitis	2.31e-06	9.45e-06	CbGpPWpGaD
Crizotinib—JAK2—Immune System—NRAS—pancreatitis	2.3e-06	9.42e-06	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—HRAS—pancreatitis	2.29e-06	9.37e-06	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—HRAS—pancreatitis	2.26e-06	9.26e-06	CbGpPWpGaD
Crizotinib—SRC—Innate Immune System—HRAS—pancreatitis	2.24e-06	9.17e-06	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—KRAS—pancreatitis	2.24e-06	9.15e-06	CbGpPWpGaD
Crizotinib—TYK2—Immune System—HRAS—pancreatitis	2.22e-06	9.09e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—MDM2—pancreatitis	2.2e-06	8.99e-06	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—IL6—pancreatitis	2.19e-06	8.96e-06	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—KRAS—pancreatitis	2.17e-06	8.88e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—KRAS—pancreatitis	2.17e-06	8.87e-06	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—IL6—pancreatitis	2.17e-06	8.86e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—LEP—pancreatitis	2.16e-06	8.86e-06	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—NRAS—pancreatitis	2.16e-06	8.85e-06	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—HRAS—pancreatitis	2.15e-06	8.81e-06	CbGpPWpGaD
Crizotinib—SRC—Innate Immune System—IL6—pancreatitis	2.15e-06	8.78e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—PLA2G1B—pancreatitis	2.14e-06	8.77e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—IL1B—pancreatitis	2.13e-06	8.73e-06	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—NRAS—pancreatitis	2.13e-06	8.73e-06	CbGpPWpGaD
Crizotinib—TYK2—Immune System—IL6—pancreatitis	2.13e-06	8.7e-06	CbGpPWpGaD
Crizotinib—JAK2—Disease—NRAS—pancreatitis	2.13e-06	8.7e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—MDM2—pancreatitis	2.12e-06	8.67e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—PTGS2—pancreatitis	2.12e-06	8.67e-06	CbGpPWpGaD
Crizotinib—LYN—Immune System—KRAS—pancreatitis	2.12e-06	8.66e-06	CbGpPWpGaD
Crizotinib—ABL1—Immune System—KRAS—pancreatitis	2.11e-06	8.62e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—INS—pancreatitis	2.09e-06	8.55e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—A2M—pancreatitis	2.07e-06	8.47e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—CCL2—pancreatitis	2.06e-06	8.41e-06	CbGpPWpGaD
Crizotinib—TYK2—Disease—HRAS—pancreatitis	2.05e-06	8.39e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—NRAS—pancreatitis	2.02e-06	8.28e-06	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—HRAS—pancreatitis	2.02e-06	8.25e-06	CbGpPWpGaD
Crizotinib—LCK—Immune System—NRAS—pancreatitis	2.02e-06	8.25e-06	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—TGFB1—pancreatitis	2.01e-06	8.22e-06	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—HRAS—pancreatitis	1.99e-06	8.13e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—MDM2—pancreatitis	1.98e-06	8.12e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—CXCL8—pancreatitis	1.98e-06	8.11e-06	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—TGFB1—pancreatitis	1.98e-06	8.11e-06	CbGpPWpGaD
Crizotinib—JAK2—Immune System—KRAS—pancreatitis	1.98e-06	8.11e-06	CbGpPWpGaD
Crizotinib—JAK2—Disease—TGFB1—pancreatitis	1.98e-06	8.08e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—NRAS—pancreatitis	1.96e-06	8.03e-06	CbGpPWpGaD
Crizotinib—TYK2—Disease—IL6—pancreatitis	1.96e-06	8.03e-06	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—IL6—pancreatitis	1.93e-06	7.9e-06	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—IL6—pancreatitis	1.9e-06	7.78e-06	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—HRAS—pancreatitis	1.9e-06	7.78e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—CASP3—pancreatitis	1.9e-06	7.76e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—ALDH2—pancreatitis	1.89e-06	7.74e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—TGFB1—pancreatitis	1.88e-06	7.69e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—NRAS—pancreatitis	1.86e-06	7.62e-06	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—KRAS—pancreatitis	1.86e-06	7.62e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—CXCL8—pancreatitis	1.86e-06	7.59e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—INS—pancreatitis	1.85e-06	7.57e-06	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—HRAS—pancreatitis	1.84e-06	7.54e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—HRAS—pancreatitis	1.84e-06	7.54e-06	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—KRAS—pancreatitis	1.84e-06	7.51e-06	CbGpPWpGaD
Crizotinib—JAK2—Disease—KRAS—pancreatitis	1.83e-06	7.48e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—LPL—pancreatitis	1.83e-06	7.48e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—TGFB1—pancreatitis	1.83e-06	7.47e-06	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—IL6—pancreatitis	1.82e-06	7.45e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—CCL2—pancreatitis	1.82e-06	7.44e-06	CbGpPWpGaD
Crizotinib—LYN—Immune System—HRAS—pancreatitis	1.8e-06	7.36e-06	CbGpPWpGaD
Crizotinib—ABL1—Immune System—HRAS—pancreatitis	1.79e-06	7.33e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—NRAS—pancreatitis	1.79e-06	7.3e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—CASP3—pancreatitis	1.78e-06	7.26e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—PPARG—pancreatitis	1.77e-06	7.23e-06	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—IL6—pancreatitis	1.77e-06	7.22e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—IL6—pancreatitis	1.76e-06	7.22e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—KRAS—pancreatitis	1.74e-06	7.12e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—MDM2—pancreatitis	1.74e-06	7.11e-06	CbGpPWpGaD
Crizotinib—LCK—Immune System—KRAS—pancreatitis	1.74e-06	7.1e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—INS—pancreatitis	1.73e-06	7.09e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—TGFB1—pancreatitis	1.73e-06	7.08e-06	CbGpPWpGaD
Crizotinib—LYN—Immune System—IL6—pancreatitis	1.72e-06	7.05e-06	CbGpPWpGaD
Crizotinib—ABL1—Immune System—IL6—pancreatitis	1.71e-06	7.01e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—KRAS—pancreatitis	1.69e-06	6.92e-06	CbGpPWpGaD
Crizotinib—JAK2—Immune System—HRAS—pancreatitis	1.68e-06	6.89e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—NRAS—pancreatitis	1.65e-06	6.74e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—CXCL8—pancreatitis	1.63e-06	6.65e-06	CbGpPWpGaD
Crizotinib—JAK2—Immune System—IL6—pancreatitis	1.61e-06	6.59e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—KRAS—pancreatitis	1.6e-06	6.55e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—NRAS—pancreatitis	1.59e-06	6.51e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—ALB—pancreatitis	1.59e-06	6.5e-06	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—HRAS—pancreatitis	1.58e-06	6.47e-06	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—HRAS—pancreatitis	1.56e-06	6.38e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—CASP3—pancreatitis	1.56e-06	6.36e-06	CbGpPWpGaD
Crizotinib—JAK2—Disease—HRAS—pancreatitis	1.56e-06	6.36e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—MDM2—pancreatitis	1.54e-06	6.29e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—KRAS—pancreatitis	1.54e-06	6.29e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—TGFB1—pancreatitis	1.53e-06	6.27e-06	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—IL6—pancreatitis	1.51e-06	6.2e-06	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—IL6—pancreatitis	1.49e-06	6.11e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—NRAS—pancreatitis	1.49e-06	6.09e-06	CbGpPWpGaD
Crizotinib—JAK2—Disease—IL6—pancreatitis	1.49e-06	6.09e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—HRAS—pancreatitis	1.48e-06	6.05e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—TGFB1—pancreatitis	1.48e-06	6.05e-06	CbGpPWpGaD
Crizotinib—LCK—Immune System—HRAS—pancreatitis	1.48e-06	6.03e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—CXCL8—pancreatitis	1.44e-06	5.89e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—HRAS—pancreatitis	1.44e-06	5.88e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—GCG—pancreatitis	1.43e-06	5.87e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—KRAS—pancreatitis	1.42e-06	5.8e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—IL6—pancreatitis	1.42e-06	5.8e-06	CbGpPWpGaD
Crizotinib—LCK—Immune System—IL6—pancreatitis	1.41e-06	5.78e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—PTGS2—pancreatitis	1.39e-06	5.69e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—TGFB1—pancreatitis	1.38e-06	5.66e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—CASP3—pancreatitis	1.38e-06	5.63e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—IL6—pancreatitis	1.38e-06	5.63e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—KRAS—pancreatitis	1.37e-06	5.6e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—HRAS—pancreatitis	1.36e-06	5.57e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—PPARG—pancreatitis	1.33e-06	5.46e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—INS—pancreatitis	1.31e-06	5.35e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—HRAS—pancreatitis	1.31e-06	5.34e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—NRAS—pancreatitis	1.3e-06	5.33e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—IL6—pancreatitis	1.3e-06	5.33e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—KRAS—pancreatitis	1.28e-06	5.24e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—IL6—pancreatitis	1.25e-06	5.11e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—TGFB1—pancreatitis	1.21e-06	4.96e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—HRAS—pancreatitis	1.21e-06	4.93e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—ALB—pancreatitis	1.2e-06	4.91e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—HRAS—pancreatitis	1.16e-06	4.76e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—NRAS—pancreatitis	1.15e-06	4.72e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—IL6—pancreatitis	1.15e-06	4.72e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—LPL—pancreatitis	1.13e-06	4.61e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—KRAS—pancreatitis	1.12e-06	4.59e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—IL6—pancreatitis	1.11e-06	4.56e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—HRAS—pancreatitis	1.09e-06	4.45e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—TGFB1—pancreatitis	1.07e-06	4.39e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—PTGS2—pancreatitis	1.05e-06	4.29e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—IL6—pancreatitis	1.04e-06	4.26e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—KRAS—pancreatitis	9.93e-07	4.06e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—HRAS—pancreatitis	9.54e-07	3.9e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—IL6—pancreatitis	9.13e-07	3.73e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—HRAS—pancreatitis	8.44e-07	3.45e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—PPARG—pancreatitis	8.22e-07	3.36e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—IL6—pancreatitis	8.08e-07	3.31e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—INS—pancreatitis	8.06e-07	3.3e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—ALB—pancreatitis	7.39e-07	3.02e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—PTGS2—pancreatitis	6.47e-07	2.65e-06	CbGpPWpGaD
